Suppr超能文献

纤溶酶原激活物抑制剂-1反应形式的模型。

A model of the reactive form of plasminogen activator inhibitor-1.

作者信息

Aertgeerts K, De Bondt H L, De Ranter C, Declerck P J

机构信息

Laboratorium voor Analytische Chemie en Medicinale Fysicochemie, Katholieke Universiteit Leuven, Belgium.

出版信息

J Struct Biol. 1994 Nov-Dec;113(3):239-45. doi: 10.1006/jsbi.1994.1058.

Abstract

A model of the reactive form of plasminogen activator inhibitor-1 (PAI-1) has been constructed using molecular graphics and starting from the known crystal structure of latent PAI-1. The residues P16 to P10', of which P16-P4 form strand 4 of the beta-sheet A (s4A) and P3-P10' form an extended loop in the latent form, have been removed and remodeled into this structure, based on the structures of ovalbumin and cleaved alpha 1-proteinase inhibitor. Residues P4'-P10' were remodeled as a beta-strand s1C, located on the surface of the molecule and the N-terminal end (P16-P14) of the eliminated loop was rebuilt using appropriate backbone dihedrals. Subsequently, a secondary structure prediction program was applied and further optimization of the model was performed by several molecular dynamics runs. Apparently the beta-strand was stabilized by only two hydrogen bonds. Further analysis revealed that, although s4A was removed, s3A and s5A did not approach each other. In this current model it was also found that the large gap between the loop connecting s4C-s3C and the loop connecting s3B-hG remained 11 A in contrast to the small gap (4A) at a similar position in other serpins. These observations may explain the ease of a conformational change of the reactive site loop of PAI-1 during transition to the latent and the preinserted form. In addition the current model can be used for the design of stable, functional, PAI-1 mutants. Detailed structural analysis of the latter may facilitate studies on the structure-function relationship in PAI-1 in particular and in other serpins in general.

摘要

已利用分子图形技术并从潜在纤溶酶原激活物抑制剂-1(PAI-1)的已知晶体结构出发构建了PAI-1反应形式的模型。基于卵清蛋白和裂解的α1-蛋白酶抑制剂的结构,去除了P16至P10'残基(其中P16 - P4形成β-折叠A的链4(s4A),P3 - P10'在潜在形式中形成一个延伸环),并将其重新构建到该结构中。P4' - P10'残基被重新构建为位于分子表面的β-链s1C,消除环的N末端(P16 - P14)使用合适的主链二面角进行了重建。随后,应用了二级结构预测程序,并通过多次分子动力学运行对模型进行了进一步优化。显然,该β-链仅通过两个氢键得以稳定。进一步分析表明,尽管s4A被去除,但s3A和s5A并未相互靠近。在当前模型中还发现,连接s4C - s3C的环与连接s3B - hG的环之间的大间隙保持为11埃,而在其他丝氨酸蛋白酶抑制剂的类似位置则为小间隙(4埃)。这些观察结果可能解释了PAI-1反应位点环在向潜在形式和预插入形式转变过程中构象变化的容易程度。此外,当前模型可用于设计稳定、有功能的PAI-1突变体。对后者的详细结构分析可能有助于特别是对PAI-1以及一般其他丝氨酸蛋白酶抑制剂的结构-功能关系的研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验